Related Experiment Video
Updated: Apr 24, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Piperacillin/Tazobactam-Induced Granulomatous Interstitial Nephritis in a Patient with Squamous Cell Lung Cancer
Takuya Sugiura1, Kazuo Tsuchiya2, Akane Koyano1
1Department of Nephrology, Shizuoka Saiseikai General Hospital, Japan.
Abstract:
Drug-induced acute interstitial nephritis (DI-AIN) is a common cause of acute kidney injury (AKI), particularly in patients receiving multiple medications. We report a case of AKI in a 47-year-old man with lung squamous cell carcinoma who was treated with carboplatin, paclitaxel, and tazobactam/piperacillin (TAZ/PIPC). A renal biopsy revealed acute tubulointerstitial nephritis with eosinophilic infiltration and non-caseating epithelioid granulomas. The drug lymphocyte stimulation test was positive for TAZ/PIPC, thus supporting a diagnosis of drug-associated DI-AIN. The discontinuation of TAZ/PIPC and corticosteroid therapy led to a recovery of the renal function, thereby allowing for the safe resumption of chemotherapy.
Insights
Drug-induced acute interstitial nephritis (DI-AIN) is a common cause of acute kidney injury (AKI). This case highlights tazobactam/piperacillin as a potential cause of DI-AIN, with prompt treatment leading to kidney function recovery.
Area of Science:
- Nephrology
- Oncology
- Pharmacology
Background:
- Drug-induced acute interstitial nephritis (DI-AIN) is a frequent cause of acute kidney injury (AKI).
- Patients undergoing chemotherapy, especially with multiple drugs, are at increased risk.
- Lung squamous cell carcinoma treatment often involves nephrotoxic agents.
Purpose of the Study:
- To report a case of AKI caused by DI-AIN in a patient treated with carboplatin, paclitaxel, and tazobactam/piperacillin.
- To investigate the specific drug responsible for DI-AIN using diagnostic tests.
- To demonstrate the successful management and recovery of renal function.
Main Methods:
- Case report of a 47-year-old male patient with lung squamous cell carcinoma.
- Renal biopsy to evaluate kidney damage.
- Drug lymphocyte stimulation test (DLST) to identify the causative agent.
- Treatment with drug discontinuation and corticosteroid therapy.
Main Results:
- Renal biopsy showed acute tubulointerstitial nephritis with eosinophilic infiltration and granulomas.
- DLST confirmed tazobactam/piperacillin as the cause of DI-AIN.
- Cessation of tazobactam/piperacillin and initiation of corticosteroids led to renal function recovery.
Conclusions:
- Tazobactam/piperacillin can induce DI-AIN, a significant cause of AKI.
- Prompt diagnosis and management, including drug withdrawal and corticosteroids, are crucial for kidney recovery.
- This approach allowed for the safe continuation of essential chemotherapy.
More Related Videos
Related Concept Videos
Atypical Pneumonia
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Pyelonephritis II: Diagnostic Studies and Management
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Acute Pyelonephritis I: Introduction

